Omada Health Partners with CVS Caremark to Enhance Weight Management Program

Omada Health, a digital health company specializing in chronic disease management, has announced a significant partnership with CVS Health's Caremark, one of the largest pharmacy benefit managers (PBMs) in the United States. This collaboration aims to bolster Caremark's weight management program by integrating Omada's expertise in lifestyle interventions and GLP-1 medication management.

Expanding PBM Partnerships

This marks Omada's second major alliance with a PBM, following its previous partnership with Cigna's Express Scripts under the EncircleRx initiative. The move underscores the growing trend of digital health companies collaborating with established healthcare players to address the rising concern of obesity and related chronic conditions.

Enhanced Care Track for GLP-1 Medications

Omada's enhanced care track program for GLP-1 drugs is designed to streamline access to these medications for employers while providing comprehensive support to patients. The program combines GLP-1 prescriptions with:

• Clinical oversight
• Lifestyle change guidance
• Guided exercise plans
• Behavioral health support
• Nutrition coaching
• Educational materials

Wei-Li Shao, president of Omada, emphasized the importance of this holistic approach: "If you're going to be on a GLP-1, you need support." The company's clinical team is specifically trained in the effective use of GLP-1s and strategies to mitigate potential side effects.

Program Success and Future Directions

Omada's GLP-1 care track has already demonstrated promising results:

• Management of 50,000 individuals through the program
• Partnerships with over 200 clients
• Observed increases in weight loss
• Indications of weight loss maintenance four months post-intervention

Looking ahead, Shao indicated that Omada plans to focus more intensively on nutrition and behavioral health aspects of weight management. "It's going to really not only be a combination of nutrition and food, but how do we help them, from a behavioral health standpoint, address the food noise, the emotional eating cravings that come back?" Shao explained.

As GLP-1 medications continue to gain attention in both societal and healthcare contexts, partnerships like this between digital health platforms and PBMs are likely to play an increasingly crucial role in managing the complexities of weight loss and obesity-related conditions.